Innate Pharma S.A. (IPHA) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Innate Pharma Sa Class A.

Watch the replay

Replay transcript excerpt

WEBVTT NOTE Transcription provided by Deepgram Request Id: 01a04559-01a0-7463-9fb2-6f87265b2a21 Created: 2026-08-27T22:30:58.278Z Duration: 2853.12 Channels: 1 00:00:01.040 -- 00:00:03.520 Thank you for standing by, and welcome to 00:00:03.520 -- 00:00:06.160 the Innate Pharma First Half twenty twenty five 00:00:06.160 -- 00:00:09.519 Business Update and Financial Results Conference Call. All 00:00:09.519 -- 00:00:11.040 lines have been placed on mute to prevent 00:00:11.040 -- 00:00:13.920 any background noise. After the speakers' remarks, there 00:00:13.920 -- 00:00:16.625 will be a question and answer session. Thank 00:00:25.345 -- 00:00:26.865 you. I'd now like to turn the call 00:00:26.865 -- 00:00:30.020 over to Stephanie Cornyn, Vice President, Investor Relations 00:00:30.020 -- 00:00:31.220 and Communications. 00:00:31.220 -- 00:00:32.180 You may begin. 00:00:33.700 -- 00:00:36.420 Good morning and good afternoon everyone. 00:00:36.580 -- 00:00:38.660 Thank you for joining us for Innate Pharma 00:00:38.660 -- 00:00:41.940 H1 twenty twenty five business update and financial 00:00:41.940 -- 00:00:43.140 results conference call. 00:00:43.735 -- 00:00:46.454 The press release and today's presentation are both 00:00:46.454 -- 00:00:49.254 available on the IR section of our website. 00:00:50.055 -- 00:00:52.454 Before we begin, I'd like to remind everyone 00:00:52.454 -- 00:00:56.375 that today's presentation includes forward looking statements based 00:00:56.375 -- 00:00:57.495 on current expectation. 00:00:58.290 -- 00:01:00.370 These statements involve 00:01:00.370 -- 00:01:03.250 risks and uncertainties that could cause actual results 00:01:03.250 -- 00:01:04.610 to differ materially. 00:01:06.610 -- 00:01:08.930 I briefly cover today's agenda. 00:01:09.330 -- ...